search
Back to results

Bridge Device for Surgical Pain for Rotator Cuff Surgery

Primary Purpose

Pain, Rotator Cuff Injuries

Status
Not yet recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Bridge Percutaneous Nerve Field Stimulator
Sponsored by
Steven Orebaugh
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pain

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Greater than 18 years of age Willing and able to provide informed consent Scheduled to undergo elective rotator cuff surgery at UPMC No pre-existing medical conditions which would prevent application of the Bridge device on auricle of ear (i.e., skin infection, rash) Exclusion Criteria: Opioids dependence Chronic pain condition with daily opioid use Anatomical malformation, which may interfere with placement of the nerve block Raynaud's disease diagnosis Vasculopathy Hemophilia or other coagulopathy, or use of active anticoagulation other than aspirin Patient refusal Pacemaker Pre-existing medical conditions which would prevent application of the Bridge device on auricle of ear (i.e., skin infection, rash) Psoriasis vulgaris

Sites / Locations

  • UPMC Outpatient Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Bridge Percutaneous Nerve Field Stimulator

Arm Description

The case group (n = 15) will receive an activated Bridge device after surgery and continuing wearing the device until post-operative day (POD) 7.

Outcomes

Primary Outcome Measures

Oral Opioid Use POD 1
This outcome will be measured by total Oral Morphine Equivalents (OME, mg) abstracted from the medical records.
Oral Opioid Use POD 2
This outcome will be measured by total Oral Morphine Equivalents (OME, mg) abstracted from the medical records.
Oral Opioid Use POD 3
This outcome will be measured by total Oral Morphine Equivalents (OME, mg) abstracted from the medical records.
Oral Opioid Use POD 4
This outcome will be measured by total Oral Morphine Equivalents (OME, mg) abstracted from the medical records.
Oral Opioid Use POD 5
This outcome will be measured by total Oral Morphine Equivalents (OME, mg) abstracted from the medical records.

Secondary Outcome Measures

Self-Reported Pain Scores POD 1
Pain scores will be completed on a Numeric Rating Scale (NRS) of 0=no pain at all and 10=the most severe pain.
Self-Reported Pain Scores POD 2
Pain scores will be completed on a Numeric Rating Scale (NRS) of 0=no pain at all and 10=the most severe pain.
Self-Reported Pain Scores POD 3
Pain scores will be completed on a Numeric Rating Scale (NRS) of 0=no pain at all and 10=the most severe pain.
Self-Reported Pain Scores POD 4
Pain scores will be completed on a Numeric Rating Scale (NRS) of 0=no pain at all and 10=the most severe pain.
Self-Reported Pain Scores POD 5
Pain scores will be completed on a Numeric Rating Scale (NRS) of 0=no pain at all and 10=the most severe pain.
Self-Reported Oral Opioid Use POD 5
Collected through the subject diary and recorded as total dosage (mg) taken
Self-Reported Oral Opioid Use POD 6
Collected through the subject diary and recorded as total dosage (mg) taken
Self-Reported Oral Opioid Use POD 7
Collected through the subject diary and recorded as total dosage (mg) taken
Self-Reported Pain Scores POD 5
Averaged NRS pain scores (0=no pain at all and 10=the most severe pain) collected via subject diary after hospital discharge every 8-hours
Self-Reported Pain Scores POD 6
Averaged NRS pain scores (0=no pain at all and 10=the most severe pain) collected via subject diary after hospital discharge every 8-hours
Self-Reported Pain Scores POD 7
Averaged NRS pain scores (0=no pain at all and 10=the most severe pain) collected via subject diary after hospital discharge every 8-hours
Adverse events related to opioid POD 5
Recorded as yes/no for adverse events related to opioids like nausea, vomiting, dizziness, and itching
Adverse events related to opioid POD 6
Recorded as yes/no for adverse events related to opioids like nausea, vomiting, dizziness, and itching
Adverse events related to opioid POD 7
Recorded as yes/no for adverse events related to opioids like nausea, vomiting, dizziness, and itching
Local adverse events on ear related to device POD 1
Recorded as yes/no for adverse events related to the device such as pain or skin irritation
Local adverse events on ear related to device POD 2
Recorded as yes/no for adverse events related to the device such as pain or skin irritation
Local adverse events on ear related to device POD 3
Recorded as yes/no for adverse events related to the device such as pain or skin irritation
Local adverse events on ear related to device POD 4
Recorded as yes/no for adverse events related to the device such as pain or skin irritation
Local adverse events on ear related to device POD 5
Recorded as yes/no for adverse events related to the device such as pain or skin irritation

Full Information

First Posted
September 24, 2023
Last Updated
October 6, 2023
Sponsor
Steven Orebaugh
Collaborators
Masimo Corporation
search

1. Study Identification

Unique Protocol Identification Number
NCT06071884
Brief Title
Bridge Device for Surgical Pain for Rotator Cuff Surgery
Official Title
Evaluation of Bridge Device in Pain Management for Outpatient Rotator Cuff Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
October 23, 2023 (Anticipated)
Primary Completion Date
February 1, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Steven Orebaugh
Collaborators
Masimo Corporation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The objective of the trial is to investigate the efficacy of the Bridge device in reducing post-operative pain and post-operative opioid consumption in patients undergoing rotator cuff surgery with the typical mode of anesthesia, nerve block plus propofol sedation.
Detailed Description
The interscalene block is the gold standard for postoperative pain management following rotator cuff surgery. However, the duration of the block does not cover rehabilitation. Therefore, in most cases, patients are discharged from the surgical center with an opioid prescription. There is a growing need to investigate complementary, non-pharmacologic pain-management methods. The Bridge device, which provides auricular neuromodulation of various cutaneous nerves near the ear, is manufactured by Masimo and previously FDA-approved to reduce symptoms of opioid withdrawal. It is a promising technology that could help relieve post-operative pain without exposing patients to the adverse effects of opioids or other pain-relieving medications. The objective of the trial is to investigate the efficacy of the Bridge device in reducing post-operative pain and post-operative opioid consumption in patients undergoing rotator cuff surgery with the typical mode of anesthesia, nerve block plus propofol sedation. Those enrolled will be assigned to a study group and compared to historic cohort (control group). Historic control group involves patients that underwent same surgical procedure performed at the surgical center involved in the study, by the same surgical operator, between 2020 and 2023.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Rotator Cuff Injuries

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
15 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Bridge Percutaneous Nerve Field Stimulator
Arm Type
Experimental
Arm Description
The case group (n = 15) will receive an activated Bridge device after surgery and continuing wearing the device until post-operative day (POD) 7.
Intervention Type
Device
Intervention Name(s)
Bridge Percutaneous Nerve Field Stimulator
Other Intervention Name(s)
NSS-2 BRIDGE
Intervention Description
The Bridge device is an FDA-cleared, drug-free, non-surgical device that uses neuro-modulation to aid in the reduction of symptoms associated with opioid withdrawal through application to branches of the Cranial Nerves V, VII, IX, X, and the occipital nerves. This study is investigating its effectiveness treating post-surgical pain.
Primary Outcome Measure Information:
Title
Oral Opioid Use POD 1
Description
This outcome will be measured by total Oral Morphine Equivalents (OME, mg) abstracted from the medical records.
Time Frame
Post-Operative Day 1
Title
Oral Opioid Use POD 2
Description
This outcome will be measured by total Oral Morphine Equivalents (OME, mg) abstracted from the medical records.
Time Frame
Post-Operative Day 2
Title
Oral Opioid Use POD 3
Description
This outcome will be measured by total Oral Morphine Equivalents (OME, mg) abstracted from the medical records.
Time Frame
Post-Operative Day 3
Title
Oral Opioid Use POD 4
Description
This outcome will be measured by total Oral Morphine Equivalents (OME, mg) abstracted from the medical records.
Time Frame
Post-Operative Day 4
Title
Oral Opioid Use POD 5
Description
This outcome will be measured by total Oral Morphine Equivalents (OME, mg) abstracted from the medical records.
Time Frame
Post-Operative Day 5
Secondary Outcome Measure Information:
Title
Self-Reported Pain Scores POD 1
Description
Pain scores will be completed on a Numeric Rating Scale (NRS) of 0=no pain at all and 10=the most severe pain.
Time Frame
Post-Operative Day 1
Title
Self-Reported Pain Scores POD 2
Description
Pain scores will be completed on a Numeric Rating Scale (NRS) of 0=no pain at all and 10=the most severe pain.
Time Frame
Post-Operative Day 2
Title
Self-Reported Pain Scores POD 3
Description
Pain scores will be completed on a Numeric Rating Scale (NRS) of 0=no pain at all and 10=the most severe pain.
Time Frame
Post-Operative Day 3
Title
Self-Reported Pain Scores POD 4
Description
Pain scores will be completed on a Numeric Rating Scale (NRS) of 0=no pain at all and 10=the most severe pain.
Time Frame
Post-Operative Day 4
Title
Self-Reported Pain Scores POD 5
Description
Pain scores will be completed on a Numeric Rating Scale (NRS) of 0=no pain at all and 10=the most severe pain.
Time Frame
Post-Operative Day 5
Title
Self-Reported Oral Opioid Use POD 5
Description
Collected through the subject diary and recorded as total dosage (mg) taken
Time Frame
Post-Operative Day 5
Title
Self-Reported Oral Opioid Use POD 6
Description
Collected through the subject diary and recorded as total dosage (mg) taken
Time Frame
Post-Operative Day 6
Title
Self-Reported Oral Opioid Use POD 7
Description
Collected through the subject diary and recorded as total dosage (mg) taken
Time Frame
Post-Operative Day 7
Title
Self-Reported Pain Scores POD 5
Description
Averaged NRS pain scores (0=no pain at all and 10=the most severe pain) collected via subject diary after hospital discharge every 8-hours
Time Frame
Post-Operative Day 5
Title
Self-Reported Pain Scores POD 6
Description
Averaged NRS pain scores (0=no pain at all and 10=the most severe pain) collected via subject diary after hospital discharge every 8-hours
Time Frame
Post-Operative Day 6
Title
Self-Reported Pain Scores POD 7
Description
Averaged NRS pain scores (0=no pain at all and 10=the most severe pain) collected via subject diary after hospital discharge every 8-hours
Time Frame
Post-Operative Day 7
Title
Adverse events related to opioid POD 5
Description
Recorded as yes/no for adverse events related to opioids like nausea, vomiting, dizziness, and itching
Time Frame
Post-Operative Day 5
Title
Adverse events related to opioid POD 6
Description
Recorded as yes/no for adverse events related to opioids like nausea, vomiting, dizziness, and itching
Time Frame
Post-Operative Day 6
Title
Adverse events related to opioid POD 7
Description
Recorded as yes/no for adverse events related to opioids like nausea, vomiting, dizziness, and itching
Time Frame
Post-Operative Day 7
Title
Local adverse events on ear related to device POD 1
Description
Recorded as yes/no for adverse events related to the device such as pain or skin irritation
Time Frame
Post-operative Day 1
Title
Local adverse events on ear related to device POD 2
Description
Recorded as yes/no for adverse events related to the device such as pain or skin irritation
Time Frame
Post-operative Day 2
Title
Local adverse events on ear related to device POD 3
Description
Recorded as yes/no for adverse events related to the device such as pain or skin irritation
Time Frame
Post-operative Day 3
Title
Local adverse events on ear related to device POD 4
Description
Recorded as yes/no for adverse events related to the device such as pain or skin irritation
Time Frame
Post-operative Day 4
Title
Local adverse events on ear related to device POD 5
Description
Recorded as yes/no for adverse events related to the device such as pain or skin irritation
Time Frame
Post-operative Day 5

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Greater than 18 years of age Willing and able to provide informed consent Scheduled to undergo elective rotator cuff surgery at UPMC No pre-existing medical conditions which would prevent application of the Bridge device on auricle of ear (i.e., skin infection, rash) Exclusion Criteria: Opioids dependence Chronic pain condition with daily opioid use Anatomical malformation, which may interfere with placement of the nerve block Raynaud's disease diagnosis Vasculopathy Hemophilia or other coagulopathy, or use of active anticoagulation other than aspirin Patient refusal Pacemaker Pre-existing medical conditions which would prevent application of the Bridge device on auricle of ear (i.e., skin infection, rash) Psoriasis vulgaris
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Carly Riedmann, BS
Phone
4126234147
Email
riedmannca@upmc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Steven L Orebaugh, MD
Organizational Affiliation
University of Pittsburgh
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Amy Monroe, MPH, MBA
Organizational Affiliation
University of Pittsburgh
Official's Role
Study Director
Facility Information:
Facility Name
UPMC Outpatient Center
City
West Mifflin
State/Province
Pennsylvania
ZIP/Postal Code
15236
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Steven Orebaugh, MD
Email
orebaughsl@anes.upmc.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Bridge Device for Surgical Pain for Rotator Cuff Surgery

We'll reach out to this number within 24 hrs